GLY-202

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGLY-202
Drug Alias Namelong acting synthetic glycoprotein hormone (GlycoForm)long acting synthetic G-CSF (GlycoForm)GLY-202
ClassificationBiologics
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlycoForm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlycoForm Ltd
Active IndicationsN/A
Inactive IndicationsNeutropenia

Other Information

ATC CodeN/A
Related LinksN/A